Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells

Metastatic colorectal cancer remains a serious health concern with poor patient survival. Although 5-Fluorouracil (5-FU) or 5-FU plus oxaliplatin (FOLFOX) is the standard therapy for colorectal cancer, it has met with limited success. Recurrence of the tumor after chemotherapy could partly be explai...

Descripción completa

Detalles Bibliográficos
Autores principales: Nautiyal, Jyoti, Kanwar, Shailender S, Yu, Yingjie, Majumdar, Adhip PN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162943/
https://www.ncbi.nlm.nih.gov/pubmed/21774804
http://dx.doi.org/10.1186/1750-2187-6-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162943/
https://www.ncbi.nlm.nih.gov/pubmed/21774804
http://dx.doi.org/10.1186/1750-2187-6-7

Ejemplares similares